Double-Blind Trial of Dexamethasone versus Methylprednisolone in Multiple Sclerosis Acute Relapses
作者:
L. La Mantia,
M. Eoli,
C. Milanese,
A. Salmaggi,
A. Dufour,
V. Torri,
期刊:
European Neurology
(Karger Available online 1994)
卷期:
Volume 34,
issue 4
页码: 199-203
ISSN:0014-3022
年代: 1994
DOI:10.1159/000117038
出版商: S. Karger AG
关键词: Multiple sclerosis;Relapse;Steroids
数据来源: Karger
摘要:
The efficacy of dexamethasone (DX) and methylprednisolone (MP) at high (HD) and low (LD) dose in acute multiple sclerosis (MS) relapses was evaluated by a double-blind trial in 31 patients followed for 1 year. DX and HDMP were similarly efficacious in promoting recovery, while LDMP was ineffective in the short-term outcome and was followed by an early clinical reactivation. The different outcomes seem to be related to different immunomodulating effects, mainly on cerebrospinal fluid (CSF) IgG synthesis and on peripheral blood and CSF CD4+ lymphocyte subsets.
点击下载:
PDF
(1031KB)
返 回